ASTHMAXcel Voice Study

Part of paid clinical trials in The Bronx, New York.

Sponsor
Montefiore Medical Center
Study ID
NCT06935084
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • ASTHMAXcel Voice platform — OTHER
    ASTHMAXcel Voice is a mobile health application with a multi-level approach to address barriers with intervention components and facilitate health behavior change through the use of push notifications and interactive educational content.

Study Details

The objective of this study is to conduct a randomized controlled trial (RCT) to compare the adapted and refined ASTHMAXcel Voice platform to usual care (UC). It is hypothesized by the investigator team that ASTHMAXcel Voice will be associated with improved clinical and process outcomes, asthma quality of life (QOL), medication adherence, and self-efficacy as compared to UC.

Key Dates

Start date
Sep 18, 2025
Status verified
Oct 2025
Primary completion
Sep 30, 2028
Completion
Sep 30, 2028

Study Design

Enrollment
200 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: ASTHMAXcel
    Participants in this arm will be provided with the adapted and refined ASTHMAXcel Voice platform.
  • No Intervention: Usual Care (UC)
    Participants in this arm will receive standard care.

Primary Outcome Measure

Change in Asthma Control [ Time Frame: Change from Baseline to 6 months after randomization ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Montefiore Medical CenterThe BronxNew York10467
Sunit Jariwala, MD
[email protected]
609-937-1023
Juliana D Rodriguez, MD
juliana.rodrí[email protected]
718-862-1722
Jonathan M Feldman, PhD (SUB_INVESTIGATOR)

Find similar trials in The Bronx, NY

By condition
Asthma
By specialty
PulmonologyLung disease
By research site
Montefiore Medical Center· The Bronx, NY

Related Studies